Randomized Controlled Trial Shows Micronutrients Reduce Severe Irritability and Suicidal Ideation in Teenagers

A new randomized controlled trial published in the Journal of the American Academy of Child & Adolescent Psychiatry —one of the most respected clinical journals in youth mental health—has found that a specialized broad-spectrum formula can significantly reduce severe irritability and suicidal ideation in adolescents.

National Media Coverage of This Research

This research has begun receiving attention from major media outlets as the implications for youth mental health become clearer. For example, coverage published by the American Psychiatric Association, The New York Post, Daily Mail, and The Conversation highlights the potential for our flagship micronutrient treatment to significantly reduce severe irritability in adolescents and reports that researchers also observed reductions in suicidal ideation in the micronutrient group.

The study, known as the BEAM trial (Balancing Emotions of Adolescents with Micronutrients), investigated whether a comprehensive micronutrient supplement, called Daily Essential Nutrients by Hardy Nutritionals, could help teenagers experiencing chronic irritability and emotional dysregulation.

The results revealed substantial improvements in the micronutrient group compared to placebo, including reductions in irritability and emotional reactivity, improvements in quality of life, and a particularly important signal: a reduction in suicidal ideation among adolescents receiving micronutrients.

The findings add to a growing body of scientific research showing that supporting the brain’s nutritional needs may play a foundational role in mental health.

Addressing Severe Irritability in Teens

Irritability is one of the most common and disruptive symptoms in adolescent mental health.

It can manifest as:

• frequent anger
• emotional outbursts
• frustration intolerance
• persistent negative mood

Importantly, irritability is not limited to one psychiatric diagnosis.

It appears across many conditions, including:

• Depression
• Anxiety disorders
• Attention-Deficit/Hyperactivity Disorder (ADHD)
• Oppositional Defiant Disorder (ODD)
• Disruptive Mood Dysregulation Disorder (DMDD)
• Other disruptive behavior disorders

Researchers have also identified irritability as a significant risk factor for suicidal thoughts and behaviors in youth, making effective treatment strategies especially important.

Despite its prevalence, irritability remains difficult to treat with conventional psychiatric approaches.

The BEAM Study: Study Method and Outcomes

Researchers enrolled 132 adolescents aged 12–17 with moderate-to-severe irritability.

Participants were randomly assigned to receive either a broad-spectrum vitamin and mineral formula (Daily Essential Nutrients by Hardy Nutritionals) or an active placebo.

The trial lasted eight weeks and used a double-blind randomized placebo-controlled design, meaning neither participants nor researchers knew who received the micronutrients until the study ended.

Researchers evaluated outcomes using:

• clinician-rated psychiatric scales
• teen self-report questionnaires
• parent-reported behavior assessments

This careful research design helps measure results across different groups of symptoms that are connected at a deeper level in the body. Many symptoms may seem separate, but they can come from underlying processes—such as how the brain makes its chemical messengers (neurotransmitters), how cells produce energy (in mitochondria), and how the body responds to stress.

A Striking Difference Between Micronutrients and Placebo

Results showed 64% of teens receiving these particular micronutrients improved compared to only 12.5% of teens who received the placebo. That represents more than a five-fold difference in treatment response.

Beyond the DMDD subgroup, adolescents receiving micronutrients also showed improvements in:

• emotional reactivity
• mood symptoms
• conduct problems
• stress levels
• prosocial behavior
• overall quality of life

Parents also reported improvements in behavior and functioning. The researchers noted that “between-group effect sizes for ODD were medium to large (0.43-0.85) and for DMDD they were large to very large, both between groups (1.04-1.44) and within group (1.30-1.53) for the micronutrient-exposed participants.” Effect size is a quantitative measure of the magnitude of the findings, representing the practical significance of the research.

Reduced Suicidal Ideation

Another notable result was the reduction in suicidal ideation reported by adolescents receiving the specialized blend of micronutrients. Although the trial was not designed specifically as a suicide-prevention study, this signal is important. Severe irritability has been linked in previous research to increased risk of suicidal thoughts and behaviors.

When an intervention reduces both irritability and suicidal ideation, it suggests that the treatment may be addressing key underlying biological mechanisms that contribute to emotional dysregulation.

Though the reduction in suicidal ideation in the youth taking micronutrients was generally impressive compared with placebo, the magnitude of reduction was most notable in youth with ODD taking the micronutrients. After 8 weeks, suicidal ideation in this subgroup was reduced to zero.

Given the rising rates of youth mental health challenges globally, findings like this highlight the importance of exploring safe and scalable interventions.

Why Micronutrients Matter for Brain Function

The brain is one of the most metabolically active organs in the body. The brain has limited energy reserves, unlike other tissues, so it must constantly generate energy.

This also means the brain uses a significant portion of the body's oxygen supply to meet these high-energy needs. To perform this function properly, the brain relies on thousands of enzymes that depend on a wide range of vitamins and minerals that serve as cofactors.

The fact that some individuals respond well to the micronutrients suggests that low concentrations of these cofactors are responsible for the brain tissue's sensitivity to metabolic dysfunction.

This biological reality is one reason the field of nutritional psychiatry has grown rapidly in recent years.

A Growing Body of Research

The BEAM trial adds to an expanding body of scientific literature examining the role of micronutrients in mental health.

Researchers are increasingly examining whether correcting nutritional deficiencies can improve mental health symptoms. In fact, Daily Essential Nutrients by Hardy Nutritionals is backed by more than 70 independent, peer-reviewed medical journal publications demonstrating its safety and efficacy in addressing mood and mental health disorders in children and adults.

Safety and Tolerability

Micronutrient supplementation in the BEAM study was generally well tolerated.

The most common side effect reported was mild gastrointestinal discomfort, primarily diarrhea, which occurred in 20.9% of participants receiving micronutrients compared to 6.2% in the placebo group. No serious adverse events were reported. Researchers concluded that the treatment appeared safe and feasible for adolescents.

A New Direction for Supporting Teen Mental Health

Mental health challenges among adolescents have increased dramatically in recent years, leaving families and clinicians searching for effective and accessible treatment options devoid of debilitating side effects or long-term health detriments.

The BEAM study provides compelling evidence that broad-spectrum micronutrient supplementation represents a promising approach to addressing severe irritability in teens. The findings could significantly influence how clinicians think about supporting emotional dysregulation and mental wellness in people of all ages.

As the science of nutritional psychiatry continues to grow, one principle is becoming increasingly clear: Optimal brain function requires optimal nutrition.

Hardy Nutritionals offers free consultations with experienced Wellness Advisors for anyone seeking mental clarity without chemical intervention. For those transitioning from psychopharmacological treatments, it is imperative that certain protocols are followed to avoid or mitigate withdrawal symptoms. Be sure to consult your prescriber before changing your supplement or medication regimen.

Visit Try.HardyNutritionals.com for more information or to order samples.

View the study here: PubMed study listing